242 related articles for article (PubMed ID: 20549894)
1. [Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy].
Nasr E; Khater S; Nehme-Nasr D; Azoury F; Jambart S
J Med Liban; 2010; 58(2):86-90. PubMed ID: 20549894
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
[TBL] [Abstract][Full Text] [Related]
4. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
[TBL] [Abstract][Full Text] [Related]
5. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience of radiation therapy for Graves' ophthalmopathy.
Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M
Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639
[TBL] [Abstract][Full Text] [Related]
8. What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
Bartalena L
Clin Endocrinol (Oxf); 2010 Aug; 73(2):149-52. PubMed ID: 20148907
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
10. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
11. [Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results].
Pitz S; Kahaly G; Rösler HP; Krummenauer F; Wagner B; Stübler M; Pfeiffer N
Klin Monbl Augenheilkd; 2002 Dec; 219(12):876-82. PubMed ID: 12548473
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
Brauer VF; Scholz GH
Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
[TBL] [Abstract][Full Text] [Related]
13. Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy.
Kulig G; Andrysiak-Mamos E; Sowińska-Przepiera E; Kulig J; Karakiewicz B; Brodowski J; Robaczyk M; Homa K; Letkiewicz M; Syrenicz A
Endokrynol Pol; 2009; 60(3):158-65. PubMed ID: 19569015
[TBL] [Abstract][Full Text] [Related]
14. Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves' ophthalmopathy.
Tsai CC; Kau HC; Tsai HH; Kao SC; Hsu WM
Eye (Lond); 2006 Sep; 20(9):1025-9. PubMed ID: 16123781
[TBL] [Abstract][Full Text] [Related]
15. Pediatric aspects in Graves' orbitopathy.
Gogakos AI; Boboridis K; Krassas GE
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
[TBL] [Abstract][Full Text] [Related]
16. A treatment strategy for Graves' orbitopathy.
Marcocci C; Pinchera A; Marinò M
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
[TBL] [Abstract][Full Text] [Related]
17. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
[TBL] [Abstract][Full Text] [Related]
18. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
19. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
[TBL] [Abstract][Full Text] [Related]
20. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]